Assessment of reproductive disorders and birth defects in communities near hazardous chemical sites .2. Female reproductive disorders

被引:10
作者
Scialli, AR
Swan, SH
Amler, RW
Baird, DD
Eskenazi, B
Gist, G
Hatch, MC
Kesner, JS
Lemasters, GK
Marcus, M
Paul, ME
Schulte, P
Taylor, Z
Wilcox, AJ
Zahniser, C
机构
[1] GEORGETOWN UNIV, MED CTR, WASHINGTON, DC 20057 USA
[2] CALIF DEPT HLTH SERV, BERKELEY, CA 94704 USA
[3] AGCY TOX SUBST & DIS REGISTRY, ATLANTA, GA USA
[4] NIEHS, RES TRIANGLE PK, NC 27709 USA
[5] UNIV CALIF BERKELEY, BERKELEY, CA 94720 USA
[6] COLUMBIA UNIV, SCH PUBL HLTH, NEW YORK, NY 10027 USA
[7] NIOSH, CINCINNATI, OH 45226 USA
[8] UNIV CINCINNATI, CINCINNATI, OH 45221 USA
[9] UNIV MASSACHUSETTS, MED CTR, WORCESTER, MA USA
[10] CTR DIS CONTROL & PREVENT, ATLANTA, GA USA
关键词
D O I
10.1016/S0890-6238(96)00107-4
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Members of the workgroup on female reproductive disorders discussed methods to evaluate five principal functions: menstrual dysfunction, infertility, pregnancy loss, lactation disorders, and pregnancy complications. To test each function, a nested strategy was considered, based on progressive levels of effort available to conduct field investigations. This strategy mas analogous to the three-tier classification of biomarkers used by other workshops. The lowest level of effort, corresponding to Tier 1, consists only of questionnaires, diaries, and reviews of maternal and infant medical records. The medium level of effort (Tier 2) collects data from questionnaires and diaries, and some biologic specimens, Suggested laboratory analyses included measurement of progesterone in saliva and several glycoprotein hormones in urine that evaluate menstrual dysfunction, infertility, and pregnancy loss. The highest level of effort (Tier 3) involves prospective collection of diary information and simultaneous collection of biological specimens. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:231 / 242
页数:12
相关论文
共 31 条
[1]  
ALBERTSON B D, 1987, Advances in Contraception, V3, P263, DOI 10.1007/BF01849284
[2]   USING THE RATIO OF URINARY ESTROGEN AND PROGESTERONE METABOLITES TO ESTIMATE DAY OF OVULATION [J].
BAIRD, DD ;
WEINBERG, CR ;
WILCOX, AJ ;
MCCONNAUGHEY, DR .
STATISTICS IN MEDICINE, 1991, 10 (02) :255-266
[3]  
Campbell K L, 1985, Res Front Fertil Regul, V3, P1
[4]  
CORSAN GH, 1990, FERTIL STERIL, V53, P591
[5]   ADVERSE PREGNANCY OUTCOMES IN RELATION TO WATER CONTAMINATION, SANTA-CLARA COUNTY, CALIFORNIA, 1980-1981 [J].
DEANE, M ;
SWAN, SH ;
HARRIS, JA ;
EPSTEIN, DM ;
NEUTRA, RR .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 129 (05) :894-904
[6]  
*DHHS, 1991, DHHS PUBLICATION
[7]   THE SIGNIFICANCE OF ELEVATED BASAL FOLLICLE-STIMULATING-HORMONE IN REGULARLY MENSTRUATING INFERTILE WOMEN [J].
EBBIARY, NAA ;
LENTON, EA ;
SALT, C ;
WARD, AM ;
COOKE, ID .
HUMAN REPRODUCTION, 1994, 9 (02) :245-252
[8]  
ESKENAZI B, 1995, AM J IND MED, V28, P817
[9]  
GRAY RH, RETROSPECTIVE PROSPE
[10]   STABILITY OF URINARY FEMALE REPRODUCTIVE HORMONES STORED UNDER VARIOUS CONDITIONS [J].
KESNER, JS ;
KNECHT, EA ;
KRIEG, EF .
REPRODUCTIVE TOXICOLOGY, 1995, 9 (03) :239-244